Literature DB >> 11798298

Characterisation of cross-reactivity of virus neutralising antibodies induced by feline panleukopenia virus and canine parvoviruses.

K Nakamura1, Y Ikeda, T Miyazawa, Y Tohya, E Takahashi, M Mochizuki.   

Abstract

It was recently reported that canine parvoviruses (CPV) had entered cat populations and induced disease in infected cats, while they had affected only dogs in the past. It is important to determine whether conventional feline panleukopenia virus (FPLV) vaccines protect against recent CPV infections. In this study, the cross-reactivity of virus-neutralising (VN) and haemagglutinin-inhibition (HI) antibodies in cats induced by FPLV and CPV s were examined. Lower cross-reactivities of VN and HI antibodies against each CPV strain were observed in cats experimentally inoculated with FPLV or vaccinated with an inactivated FPLV vaccine. In addition, we revealed the existence of a novel type of FPLV, which reacted weakly with antibodies induced by the conventional FPLV vaccine. Copyright 2001 Harcourt Publishers Ltd.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11798298     DOI: 10.1053/rvsc.2001.0492

Source DB:  PubMed          Journal:  Res Vet Sci        ISSN: 0034-5288            Impact factor:   2.534


  8 in total

1.  Characterization of the partial VP2 gene region of canine parvoviruses in domestic cats from Turkey.

Authors:  Dilek Muz; T Ciğdem Oğuzoğlu; M Ozkan Timurkan; Hümay Akın
Journal:  Virus Genes       Date:  2011-12-30       Impact factor: 2.332

2.  Feline host range of canine parvovirus: recent emergence of new antigenic types in cats.

Authors:  Yasuhiro Ikeda; Kazuya Nakamura; Takayuki Miyazawa; Eiji Takahashi; Masami Mochizuki
Journal:  Emerg Infect Dis       Date:  2002-04       Impact factor: 6.883

3.  Molecular analysis of carnivore Protoparvovirus detected in white blood cells of naturally infected cats.

Authors:  Andrea Balboni; Francesca Bassi; Stefano De Arcangeli; Rosanna Zobba; Carla Dedola; Alberto Alberti; Mara Battilani
Journal:  BMC Vet Res       Date:  2018-02-05       Impact factor: 2.741

4.  Adeno-associated virus-binding antibodies detected in cats living in the Northeastern United States lack neutralizing activity.

Authors:  Kei Adachi; Gregory A Dissen; Alejandro Lomniczi; Qing Xie; Sergio R Ojeda; Hiroyuki Nakai
Journal:  Sci Rep       Date:  2020-06-22       Impact factor: 4.379

5.  Characterisation of canine parvovirus strains isolated from cats with feline panleukopenia.

Authors:  Nicola Decaro; Domenico Buonavoglia; Costantina Desario; Francesca Amorisco; Maria Loredana Colaianni; Antonio Parisi; Valentina Terio; Gabriella Elia; Maria Stella Lucente; Alessandra Cavalli; Vito Martella; Canio Buonavoglia
Journal:  Res Vet Sci       Date:  2010-03-23       Impact factor: 2.534

6.  Evaluation of an in-house indirect enzyme-linked immunosorbent assay of feline panleukopenia VP2 subunit antigen in comparison to hemagglutination inhibition assay to monitor tiger antibody levels by Bayesian approach.

Authors:  Chanakan Areewong; Amarin Rittipornlertrak; Boondarika Nambooppha; Itsarapan Fhaikrue; Tawatchai Singhla; Chollada Sodarat; Worapat Prachasilchai; Preeyanat Vongchan; Nattawooti Sthitmatee
Journal:  BMC Vet Res       Date:  2020-08-06       Impact factor: 2.741

7.  Feline Parvovirus Seroprevalence Is High in Domestic Cats from Disease Outbreak and Non-Outbreak Regions in Australia.

Authors:  Elizabeth Jenkins; Conor Davis; Maura Carrai; Michael P Ward; Susan O'Keeffe; Martine van Boeijen; Louise Beveridge; Costantina Desario; Canio Buonavoglia; Julia A Beatty; Nicola Decaro; Vanessa R Barrs
Journal:  Viruses       Date:  2020-03-16       Impact factor: 5.048

Review 8.  Feline panleukopenia. ABCD guidelines on prevention and management.

Authors:  Uwe Truyen; Diane Addie; Sándor Belák; Corine Boucraut-Baralon; Herman Egberink; Tadeusz Frymus; Tim Gruffydd-Jones; Katrin Hartmann; Margaret J Hosie; Albert Lloret; Hans Lutz; Fulvio Marsilio; Maria Grazia Pennisi; Alan D Radford; Etienne Thiry; Marian C Horzinek
Journal:  J Feline Med Surg       Date:  2009-07       Impact factor: 2.015

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.